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Abstract
Multimodal pain management is the use of combinations of medications from different
classes or medications with different routes of delivery to optimize pain relief. The
adjunctive use of multiple analgesic agents is associated with better pain relief and fewer
adverse effects. Intravenous acetaminophen offers a relatively low risk, safe adjunct to
multimodal therapy. A comparative retrospective chart review showed that adult patients
undergoing laparoscopic appendectomy or cholecystectomy surgery who received
intravenous acetaminophen in the operating room had a reduced opioid requirement
directly after surgery, in the post anesthesia care unit. A total of 34 doses of opioids
(Fentanyl and Dilaudid) were given to the group who received the intravenous
acetaminophen as compared to 65 doses of the same opioids given to the group that did
not. Since only two surgical procedures were studied, the results may not be applicable to
other surgical procedures. Additionally, the small sample size (60 patient charts) was a
noted limitation. Data is consistent with previous studies supporting the use of
intravenous acetaminophen to help reduce the amount of opioid use postoperatively
Because of its relatively safe profile, intravenous acetaminophen should be thoughtfully
considered when addressing pain management in the operative setting.
Keywords: postoperative pain, acetaminophen injection, acetaminophen IV, intravenous
paracetamol, laparoscopic surgery and IV acetaminophen.
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Statement of Problem
Ambulatory surgical procedures now make up 70% of the total volume of
hospital-based elective surgical procedures. Postoperative pain, nausea, and vomiting are
the most common factors leading to delays in outpatient discharge and admissions to the
hospital following ambulatory surgery.1 Multimodal pain management, also known as
balanced analgesia, is defined as using combinations of medications from different
classes or medications with different routes of delivery to optimize pain relief and
minimize adverse effects.2 It is fast replacing traditional pain treatment options.3 Pain
control regimens should not be standardized but tailored to the needs of the individual
patient, taking into account medical, psychological, and physical condition, age, level of
fear or anxiety, surgical procedure, personal preference and response to agents given.4
The adjunctive use of multiple analgesic agents is associated with better pain relief, fewer
significant adverse effects, facilitation of earlier recovery and improved patient outcomes
and satisfaction.5
Literature Review
Opioids have long been the mainstay of postoperative pain, but the long list of
associated adverse effects has given support to the multimodal approach to pain
management. Treatment plans that use only opioids run the risk of intolerable and
dangerous adverse effects. Common side effects of opioid administration include
sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance and
respiratory depression.6 The financial burden of these side effects can be seen in
increased lengths of hospitalization stay, unexpected admission to the hospital,
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administration of additional medications to treat the side effects, the potential for
unexpected intubation to protect the airway in the event of over-sedation, and an
abundance of additional burdens should the patient become opioid dependent.
Additionally, opioid-induced hyperalgesia, a condition in which increasing dosages of
opioid consumption result in an increased sensitivity to pain, can result.7
Multimodal analgesia, utilizing regional analgesic techniques, where possible, and
non-opioid analgesics, appears to represent a viable strategy to decrease systemic opioid
consumption and improve postoperative analgesia.8 In the United States (US), there are a
number of nonopioid oral analgesics that, given alone or in combination with opioids, are
approved and frequently used for acute pain management. While these agents are
typically not sufficient to treat moderate-to-severe pain by themselves, they are useful
adjuncts to opioids.9 The American Society of Anesthesiologists recommended that,
unless contraindicated, all post surgical patients should receive an around-the-clock
regimen of a non-opioid agent.10
Until the Federal Drug Administration (FDA) approved intravenous
acetaminophen in 2010, there were only two approved intravenous non-opioid analgesics
available for use for multimodal pain management: ketorolac and ibuprofen, both of
which are NSAIDs. Intravenous (IV) NSAIDs have potential adverse events as well,
including bleeding and renal toxicity, which limits their use in the perioperative setting.11
Acetaminophen is the most widely used analgesic and antipyretic in the US, and is
considered the first line drug of choice by the World Health Organization (WHO). It has
been used in Europe for many years under the generic name paracetamol. Intravenous
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acetaminophen represents a relatively new drug for the short-term treatment of mild to
moderate pain, and moderate to severe pain with adjunctive opioid use. Acetaminophen
injection, which is marketed in the US as Ofirmev, provides a significant level of
analgesia after a 15 minute infusion.12 Acetaminophen IV now provides another
therapeutic option for hospitalized patients unable to take oral medications, particularly in
the peri-operative setting.13
Intravenous acetaminophen is administered as a 15 minute infusion. The
recommended dosage in adults and adolescents weighing more than fifty kilograms is one
gram, up to four times per day, with a minimum interval of four hours between doses and
a maximum daily dose of four grams.14 The advantage of using IV acetaminophen in a
multimodal approach is that it is safe to use in conjunction with other drugs, and has few
clinically significant drug interactions.15 Its efficacy and tolerability are well established
and in contrast with opioid analgesics, it has a favorable safety profile.16 Unlike NSAIDs,
it does not produce gastrointestinal damage. It should be used with caution in patients
with hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition,
severe hypovolemia or severe renal impairment, and it should not be used in patients with
acetaminophen allergy.17While the mechanism of acetaminophen-mediated pain relief is
still not completely understood, it has been shown that it rapidly enters the intact central
nervous system (CNS) and the majority of the mechanisms involved in analgesia occur in
the CNS.18
Wininger and associates (2010) conducted a randomized, double-blind, placebocontrolled, parallel-group study at 17 US sites to evaluate the analgesic efficacy and
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safety of repeated doses of two dosing regimens of IV acetaminophen compared with
placebo over 24 hours in subjects with moderate to severe pain after abdominal
laparoscopic surgery. A total of 244 subjects were randomized. Both regimens of IV
acetaminophen (1000 milligrams every six hours vs. 650 milligrams every four hours)
were associated with statistically significant analgesic efficacy compared with placebo
and were well tolerated. These results are consistent with those of previously published
studies in which IV acetaminophen was reported to be more effective than placebo and
comparable to several nonopioid and opioid analgesics in the treatment of postoperative
acute pain in a wide variety of surgical settings, ranging from tonsillectomy and
endoscopic sinus surgery to spine and cardiac surgery.
Marcario and Royal (2010) performed a literature review of randomized clinical
trials of IV acetaminophen for acute postoperative pain.
Sixteen articles from nine countries published between 2005 and 2010 met
inclusion criteria and had a total of 1,464 patients. In seven of the eight studies where IV
acetaminophen was compared with an active comparative medication, IV acetaminophen
was found to have similar analgesic outcomes. Three of the eight studies also found IV
acetaminophen resulted in a significant reduction in mean opioid consumption. Twelve
of 14 placebo-controlled studies found that IV acetaminophen patients had improved pain
relief. The limitations of the studies reviewed were small sample size (only 5 of the 16
studies included more than 40 patients in the acetaminophen group). Additionally,
because the best analgesic approach needs to be individualized to the specific surgical
procedure, results from a specific study may not be applicable to other surgery types or
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when other analgesic interventions such as nerve blocks are added to a multimodal
approach.19
Clinically, the goal is to advance simple, safe, effective therapies that will reduce
postoperative pain. Reduction of pain and reduction of adverse side effects ultimately
leads to safe, effective patient outcomes. The purpose of this project was to investigate
the relationship between the use of IV acetaminophen in the operating room (OR) and the
opioid requirement in the post anesthesia care unit (PACU) in patients undergoing
laparoscopic appendectomies and laparoscopic cholecystectomies.

Method
Study Design
This study used a two group design. Group One included subjects who received
the standard dose of IV acetaminophen in the OR during an appendectomy or
cholecystectomy and Group Two were subjects who did not receive the IV
acetaminophen.
Site and Sample
This research study was conducted at a 350 bed acute care hospital in Rhode
Island. The sample was selected from subjects over the age of 18 who had undergone
laparoscopic appendectomies and laparoscopic cholecystectomies and who met the
inclusion criteria. Inclusion criteria included adult patients who received
IVacetaminophen during the course of laparoscopic appendectomy or laparoscopic
cholecystectomy surgery and who were able to verbally enumerate their level of pain in
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the post-operative care unit (PACU). The numeric pain scale 0-10, where 0 equals no
pain and 10 equals intolerable pain, was used. Exclusion criteria included patients who
were opioid dependent prior to surgery, those that used analgesics or alcohol chronically,
those with chronic hepatic failure, and those with an allergy to acetaminophen as noted
on the pre-operative interview by the anesthesiologist. Patients receiving nerve blocks or
those that have any pain control devices, such as a patient-controlled analgesia (PCA)
pump or opioid medication patches were also excluded. Additionally, patients whose
pain level was documented in a scale other than the numeric pain scale were excluded.
Procedures
Approval was obtained from the institutional and RIC IRB. The student
researcher developed a data collection tool derived from the review of the literature and
clinical experience. The written anesthesia record was used to review the pre-operative
interview data obtained by the anesthesiologist in order to identify potential exclusions.
The intraoperative record was reviewed to ascertain whether the patient received IV
acetaminophen in the operating room. The patient electronic record was surveyed to
obtain the pain scale and medication interventions used in the post anesthesia care unit
(PACU). including IV acetaminophen and other analgesics. Pain scores were recorded
from PACU admission, at 15 minutes, 30 minutes, and every 15 minutes thereafter until
transfer from PACU to the outpatient area (for those patients going home) or admission
to a hospital bed (for those patients being admitted). The total amount of opioid
analgesia use was collected and compared between the two groups.
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Data analysis included a comparison of the number of patients reporting pain
between the two groups as well as the number of doses of IV Fentanyl and IV Dilaudid
given to patients in each group.
Results
A total of 94 charts were reviewed. Of those, 60 who met eligibility criteria
were included: 30 who received IV acetaminophen (Group One) and 30 who did not
receive IV acetaminophen (Group Two). Table 1 illustrates the number of patients
reporting pain in each group from arrival to PACU and in 15 minute increments
thereafter. Of the 30 patients who did NOT receive IV acetaminophen in the OR (Group
Two), 23 reported pain levels during their stay in the PACU sufficient to require IV
opioid administration while 7 did not report pain levels requiring opioids. Of the 30
patients who did receive the IV acetaminophen (Group One), 16 reported pain levels
sufficient to require IV opioids, and 14 did not require IV opioids. Only one patient in
Group One required an opioid on arrival to PACU, while three patients in Group Two
had a pain level requiring the use of an IV opioid. At every time increment, with the
exception of the 15 minute time period, more patients in Group Two experienced pain
compared to Group One. Additionally, over time, Group One had a higher percentage of
reduction in the number of patients reporting pain compared to Group Two.
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Table Two illustrates the number of doses of IV Fentanyl that were given between the
two groups. The standard dose of Fentanyl was 50 mcg IV, which could be repeated in
five minutes, for a total of 100 mcg of Fentanyl. A total of 27 doses of IV Fentanyl (50
mcg) was given to patients who received IV acetaminophen in the OR, as compared to 41
doses given to the patients who did not. Additionally, on arrival, at 30 minutes, 60
minutes and 75 minutes, at least twice as many doses of Fentanyl were given to the group
not receiving acetaminophen.
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Table 3 compares the number of doses of IV Dilaudid (1 mg) given between the two
groups. After the 100 mcg of IV Fentanyl had been administered, the standard was to
give one milligram of IV Dilaudid, which could be repeated after five minutes, for a total
of two mgs. A total of seven doses were administered to the group receiving IV
acetaminophen as compared to 24 doses given to the group not receiving it.
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Discussion

The data presented in this study is consistent with previous studies that supported
the use of IV acetaminophen intra-operatively to reduce the amount of opioids used
postoperatively in these two surgical procedures. In the hospital where the data were
collected, the standard for pain management is to medicate for pain levels greater than
three on a zero to 10 numeric scale. The data collected and presented in this study
suggests that patients who receive IV acetaminophen in the OR report less pain in the
recovery room and, therefore, require less opioid pain medication in these two surgical
procedures.
This study was a retrospective chart audit, so was limited by the data that
was documented. The sample size was small and data were collected at one institution;
further study is indicated. The author did not examine individual pain levels with each
reported pain experience, so there is no way of knowing at what reported pain level
individual patients were medicated. Anecdotally, some surgeons were found to be
resistant to using IV acetaminophen in the OR if their patients were going home with a
prescription for pain medication that contained acetaminophen in it. These surgeons
verbalized a fear that those patients might exceed the maximum recommended dose of
four grams of acetaminophen a day.
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Conclusions and Recommendations.
Given the relative safety of IV acetaminophen, prior research, and results of this
study, the author recommends that institutions give careful consideration to the use of IV
acetaminophen. The dangers of opioids are well documented, and opioids contribute to
post-operative and post discharge nausea and vomiting. Dosing schedules are available
that take into account the acetaminophen given in the OR and what can be given to
patients upon discharge to ensure safe dosing. Safe and effective pain management is a
critical patient safety goal following any surgical procedure. The use of IV
acetaminophen offers a safe adjunct in the multi-modal approach to pain control in the
surgical setting. The APRN can be influential in policy development, practice change,
and in working across systems and within teams to promote the use of intravenous
acetaminophen as an important component in assuring safe and effective pain
management in the surgical setting.

13

References
1. Crews, J. C., MD (2002, August 7). Multimodal Pain Management Strategies for
Office-Based and Ambulatory Procedures. JAMA, 288, 629-632.
2. Jones, V. (2011). Acetaminophen Injection: A review of Clinical Information. Journal
of Pain & Palliative Care Pharmacotherapy, 25, 340-349.
3. Salihoglu, Z., MD, Yildirim, M., MD, Demiroluk, S., MD, Kaya, G., MD, Karatas, A.,
MD, Ertem, M., MD, & Aytac, E., MD (2009, August). Evaluation of Intravenous
Paracetamol Administration on Postoperative Pain and Recovery Characteristics
in Patients Undergoing Laparoscopic Cholecystectomy. Surgical
laparoscopy,endoscopy & percutaneous techniques, 19, 321-323.
4. Kodali, B., MD, & Oberoi, J. S., MD (2012). Management of Postoperative Pain.
UpToDate. Retrieved from www.uptodate.com
5.Salihoglu, Z., MD, Yildirim, M., MD, Demiroluk, S., MD, Kaya, G., MD, Karatas, A.,
MD, Ertem, M., MD, & Aytac, E., MD (2009, August). Evaluation of Intravenous
Paracetamol Administration on Postoperative Pain and Recovery Characteristics
in Patients Undergoing Laparoscopic Cholecystectomy. Surgical
laparoscopy,endoscopy & percutaneous techniques, 19, 321-323.
6. Crews, J. C., MD (2002, August 7). Multimodal Pain Management Strategies for
Office-Based and Ambulatory Procedures. JAMA, 288, 629-632.

14

7. Pasero, C., MS, RN-BC, FAAN, & S Dannard, D., PhD, RN, CCRN, CCNS, FCCM
(2012, June). The Role Of Intravenous Acetaminophen in Acute Pain
Management: A Case-Illustrated Review. Pain Management Nursing, 13(2).

8. Smith, H. S., MD (2011). Perioperative Intravenous Acetaminophen and NSAIDs.
Pain Medicine, 12, 961-981
9. Smith, H. S., MD (2011). Perioperative Intravenous Acetaminophen and NSAIDs.
Pain Medicine, 12, 961-981
10. Practice Guidelines for Acute Pain Management in the Perioperative Setting. (2004).
Anesthesiology, 1573-1581.
11. Wininger, S. J., MD, Miller, H., MD, Minkowitz, H., MD, Royal, M. A., MD, JD,
MBA, Ang, R. Y., MD, Breitmeyer, J. B., MD, PhD, & Singla, N., MD (2010,
November 14). A Randomized, Double-Blind, Placebo-Controlled, Multicenter,
Repeat-Dose Study of Two Intravenous Acetaminophen Dosing Regimens for the
Treatment of Pain After Abdominal Laparoscopic Surgery. Clinical
Therapeurtics, 32, 2348-2369.
12. Jones, V. (2011). Acetaminophen Injection: A review of Clinical Information.
Journal of Pain & Palliative Care Pharmacotherapy, 25, 340-349.
13. Jones, V. (2011). Acetaminophen Injection: A review of Clinical Information.
Journal of Pain & Palliative Care Pharmacotherapy, 25, 340-349.
14. Duggan, S., & Scott, L. (2009). Intravenous Paracetamol (Acetaminophen) (ADIS
Drug Profile). Auckland, New Zealand: Adis Data Information

15

15. Cadence Pharmaceuticals. Inc. (2010). OFIRMEV (acetaminophen) Injection for
Intravenous Use.

16. Cadence Pharmaceuticals. Inc. (2010). OFIRMEV (acetaminophen) Injection for
Intravenous Use.
17. Cadence Pharmaceuticals. Inc. (2010). OFIRMEV (acetaminophen) Injection for
Intravenous Use.
18. Smith, H. S., MD (2011). Perioperative Intravenous Acetaminophen and NSAIDs.
Pain Medicine, 12, 961-981.
19. Marcario, A., & Royal, M. (2010, Nov 28). A Literature Review of Randomized
Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute
Postoperative Pain. Pain Practice.

16

